
Opinion|Videos|April 30, 2025
Regulatory Requirements and Credentialing for Pharmacy-Based Point-of-Care Testing
Author(s)Duane Jones, BS Pharm
A panelist discusses how obtaining a Clinical Laboratory Improvement Amendments (CLIA) waiver is an essential regulatory step for pharmacies to perform point-of-care testing, followed by credentialing with payers to receive reimbursement for these services.
Advertisement
Episodes in this series

Regulatory Framework and Credentialing
Main Discussion Topics:
- CLIA waiver requirements and regulatory compliance
- Pharmacist credentialing process with payers
- Documentation and protocol development importance
Key Points for Physicians:
- 48 states allow pharmacists to perform point-of-care testing
- Pharmacy testing requires CLIA waivers
- Pharmacies must establish protocols similar to those in medical practice settings
Notable Insights:
- Credentialing is a one-time process that creates ongoing opportunity
- Creating standardized documentation during initial implementation simplifies future onboarding
- State health departments often provide guidance and support for implementing testing programs
Clinical Significance:
Although regulatory and credentialing processes require an initial investment of time, they establish the foundation for pharmacy-based clinical services that can expand health care access points and create sustainable revenue streams through formalized medical billing pathways.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Updated COVID-19 Vaccines Effectively Protect Against Symptomatic Infection
2
Serotype 4 IPD Threat for Young Adults, Unvaccinated Men
3
Pharmacists Need Legal, Training Support to Advance Vaccination
4
Pandemic-Era Household Stress Hit Nearly Half of Pregnant Women
5






















